Remission could be predicted by sputum markers in severe asthma after therapy targeting anti interleukin-5 receptor - Vienna 2024

Clinical outcomes and translational aspects in severe asthma

Chair(s): Freda Yang, Fabio L. M. Ricciardolo

Session type: Oral presentation

Remission could be predicted by sputum markers in severe asthma after therapy targeting anti interleukin-5 receptor

Catherine Moermans

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Proteome profiling of plasma reveals biomarkers of COPD associated pulmonary hypertension

Xuefei Liu

Replay

Poster

Abstract

Slides

The patient health-related quality of life (HRQoL) burden of severe asthma in Europe (SHARP CRC) for specific subgroups

Lianne Ten Have

Replay

Poster

Abstract

Slides

Remission could be predicted by sputum markers in severe asthma after therapy targeting anti interleukin-5 receptor

Catherine Moermans

Replay

Poster

Abstract

Slides

Fixed-dose fluticasone propionate/salmeterol (FP/SAL) and budesonide/formoterol (BUD/FOR) comparative effectiveness in moderatesevere asthma: US database analysis

Richard Stanford

Replay

Poster

Abstract

Slides

DARWIN EU® - Background rates of clinical outcomes of interest in patients with severe asthma

Katia Mc Verhamme

Replay

Poster

Abstract

Slides

T1/T3 pathways and chemokines in mild-to-severe neutrophilic asthma

Elisa Arrigo

Replay

Poster

Abstract

Slides

Towards a paradigm shift in Severe Asthma Management: deep analysis of the effect of suBmaximal Aerobic training (SAMBA)

Florence Schleich

Replay

Poster

Abstract

Slides

Are circulating CC10 levels and gene G38A polymorphism associated with subsequent asthma outcomes in patients with moderate-to-severe asthma ?

A?da Diop

Replay

Poster

Abstract

Slides

A Three-Year Review of Benralizumab Therapy: Long-Term Control of Eosinophilic Asthma and Associated Risks

Nimr?d L?szl?

Replay

Poster

Abstract

Slides

Rate of admission and readmission to the ED among patients with severe asthma

Irvin Mayers

Replay

Poster

Abstract

Slides

Discussion and Q&A

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}